Pulse Biosciences, Inc. (PLSE) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In USD
| Market Cap | 925.34M |
| Enterprise Value | 852.13M |
| P/E Ratio | -43.09 |
| PEG Ratio | 4.36 |
| Price/Sales Ratio | 2,944.77 |
| Price/Book Ratio | 35.07 |
| Enterprise/Revenue | 2,864.73 |
| Enterprise/EBITDA | -42.51 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | June 30, 2026 |
| Profit Margin | -67.56 |
| Operating Margin | -70.08 |
| Return On Assets | -0.69 |
| Return On Equity | -0.94 |
| Revenue | 350,000 |
| Revenue/Share | 0.02 |
| Gross Profit | -1.26M |
| EBITDA | -71.71M |
| Net Income | -72.78M |
| Diluted EPS | -1.08 |
| Total Cash | 101.62M |
| Total Cash/Share | 1.47 |
| Total Debt | 6.77M |
| Total Debt/Equity | 0.07 |
| Current Ratio | 9.63 |
| Book Value Per Share | 1.44 |
| 52-Week Change | 195.72 |
| 52-Week High | 50.71 |
| 52-Week Low | 12.56 |
| Moving Average 50 Days | 33.01 |
| Moving Average 200 Days | 22.31 |
| Average Volume | 375,469 |
| Shares Outstanding | 69.21M |
| % Held by Institutions | 11.46 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |